VenetoclaxMeSH concept

https://www.has-sante.fr/jcms/p_3448141/fr/venclyxto-venetoclax-leucemie-lymphoide-chronique
2023
France
evaluation of the transparency committee
venetoclax
venetoclax
leukaemia
leukemia, lymphoid
Chronic lymphocytic leukemia
chronic lymphocytic leukemia
leukemia, lymphocytic, chronic, B-Cell

---
https://www.has-sante.fr/jcms/p_3351236/fr/venclyxto-venetoclax-leucemie-lymphoide-chronique
2022
false
false
false
France
Obinutuzumab/Venetoclax Regimen
evaluation of the transparency committee
venetoclax
chronic lymphocytic leukemia
leukemia, lymphoid
leukemia, lymphocytic, chronic, B-Cell
Chronic lymphocytic leukemia
leukaemia
venetoclax

---
https://www.has-sante.fr/jcms/p_3367900/fr/venclyxto-venetoclax-llc-en-association-avec-l-obinutuzumab
2022
France
evaluation of the transparency committee
venetoclax
obinutuzumab
association
venetoclax
obinutuzumab
leukemia, lymphocytic, chronic, B-Cell

---
https://ansm.sante.fr/tableau-atu-rtu/venetoclax-abbvie-10-mg-50-mg-et-100-mg-comprimes-pellicules
2016
false
false
false
France
French
summary of product characteristics
package leaflet
guidelines for drug use
adult
leukemia, lymphocytic, chronic, B-Cell
chromosome 17 deletion
mutation
TP53 Gene
venetoclax
administration, oral
antineoplastic agents
drug evaluation, preclinical
treatment outcome
Proto-Oncogene proteins c-bcl-2
venetoclax
venetoclax
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
Smith-Magenis syndrome
chromosome deletion
chromosomes, human, pair 17

---
https://www.ema.europa.eu/medicines/human/EPAR/Venclyxto
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
venetoclax
venetoclax
leukemia, lymphocytic, chronic, B-Cell
drug approval
europe
risk assessment
pregnancy
breast feeding
drug interactions
administration, oral
B-Cell leukemia 2 family proteins
antineoplastic agents
antineoplastic agents
leukemia, lymphocytic, chronic, B-Cell
Loss of Chromosome 17p
genes, p53
product surveillance, postmarketing
mutation
continuity of patient care
drug monitoring
adult
aged
drug evaluation, preclinical
Response Rate
venetoclax
venetoclax
venetoclax
Proto-Oncogene proteins c-bcl-2
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic
sulfonamides
Bridged Bicyclo Compounds, Heterocyclic

---